Molecular Therapy - Oncolytics
Volume 18, 25 September 2020, Pages 137-148
Original ArticleA Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway
Under a Creative Commons license
open access
Graphical Abstract
Keywords
chronic myeloid leukemia
imatinib resistance
BCR-ABL kinase
targeted therapies
cell differentiation
BCR-ABL mutations
JAK-STAT pathway
T315I mutation
Cited by (0)
- 7
These authors contributed equally to this work.
© 2020 The Authors.